Dr. Anurag K. Singh
Claim this profileRoswell Park Cancer Institute
Studies Cancer
Studies Squamous Cell Carcinoma
13 reported clinical trials
21 drugs studied
Area of expertise
1Cancer
p16 negative
p16 positive
Stage IV
2Squamous Cell Carcinoma
p16 negative
p16 positive
Stage IV
Affiliated Hospitals
Clinical Trials Anurag K. Singh is currently running
High-Dose vs Low-Dose Cisplatin with Radiation
for Head and Neck Cancer
This phase II/III trial compares the effect of the combination of high-dose cisplatin every three weeks and radiation therapy versus low-dose cisplatin weekly and radiation therapy for the treatment of patients with locoregionally advanced head and neck cancer. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer.
Recruiting1 award Phase 2 & 335 criteria
Chemotherapy + Radiation Therapy
for Head and Neck Cancer
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
More about Anurag K. Singh
Clinical Trial Related2 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Anurag K. Singh has experience with
- Cisplatin
- Intensity-Modulated Radiation Therapy
- Stereotactic Body Radiation Therapy
- Photoacoustic Imaging
- Docetaxel
- Quality Of Life Intervention
Breakdown of trials Anurag K. Singh has run
Cancer
Squamous Cell Carcinoma
Lung Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anurag K. Singh specialize in?
Anurag K. Singh focuses on Cancer and Squamous Cell Carcinoma. In particular, much of their work with Cancer has involved p16 negative patients, or patients who are p16 positive.
Is Anurag K. Singh currently recruiting for clinical trials?
Yes, Anurag K. Singh is currently recruiting for 7 clinical trials in Buffalo New York. If you're interested in participating, you should apply.
Are there any treatments that Anurag K. Singh has studied deeply?
Yes, Anurag K. Singh has studied treatments such as Cisplatin, Intensity-Modulated Radiation Therapy, Stereotactic Body Radiation Therapy.
What is the best way to schedule an appointment with Anurag K. Singh?
Apply for one of the trials that Anurag K. Singh is conducting.
What is the office address of Anurag K. Singh?
The office of Anurag K. Singh is located at: Roswell Park Cancer Institute, Buffalo, New York 14263 United States. This is the address for their practice at the Roswell Park Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.